Product Name

  • Name

    Abiraterone

  • EINECS 810-941-6
  • CAS No. 154229-19-3
  • Article Data46
  • CAS DataBase
  • Density 1.14 g/cm3
  • Solubility
  • Melting Point 227-228 °C(Solv: toluene (108-88-3))
  • Formula C24H31NO
  • Boiling Point 500.17 °C at 760 mmHg
  • Molecular Weight 349.516
  • Flash Point 256.294 °C
  • Transport Information
  • Appearance white solid
  • Safety
  • Risk Codes
  • Molecular Structure Molecular Structure of 154229-19-3 (Abiraterone)
  • Hazard Symbols
  • Synonyms 17-(3-Pyridyl)androsta-5,16-dien-3beta-ol;CB 7598;Androsta-5,16-dien-3-ol,17-(3-pyridinyl)-, (3b)-;
  • PSA 33.12000
  • LogP 5.39860

Synthetic route

abiraterone acetate
154229-18-2

abiraterone acetate

abiraterone
154229-19-3

abiraterone

Conditions
ConditionsYield
With lithium hydroxide monohydrate In tetrahydrofuran; water at 0 - 20℃; for 48h; Inert atmosphere;99%
With lithium hydroxide In tetrahydrofuran; methanol; water for 1h;96%
With sodium hydroxide In methanol at 20℃; for 2h; Reagent/catalyst;95.8%
C27H39NOSi

C27H39NOSi

abiraterone
154229-19-3

abiraterone

Conditions
ConditionsYield
With hydrogenchloride In methanol; water at 20 - 30℃; for 1.5h; pH=1 - 2;96.6%
With tetrabutyl ammonium fluoride In dichloromethane at 20℃;90%
3-((3S,8R,9S,10R,13S,14S)-3-((tert-butyldimethylsilyl)oxy)-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl)pyridine
1421704-60-0

3-((3S,8R,9S,10R,13S,14S)-3-((tert-butyldimethylsilyl)oxy)-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl)pyridine

abiraterone
154229-19-3

abiraterone

Conditions
ConditionsYield
With hydrogenchloride In methanol; water at 20 - 30℃; for 1h;96.5%
Stage #1: 3-((3S,8R,9S,10R,13S,14S)-3-((tert-butyldimethylsilyl)oxy)-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl)pyridine With tetrabutyl ammonium fluoride In tetrahydrofuran
Stage #2: With water In tetrahydrofuran
89%
With tetrabutyl ammonium fluoride In tetrahydrofuran89%
C43H45NO

C43H45NO

abiraterone
154229-19-3

abiraterone

Conditions
ConditionsYield
With hydrogenchloride In methanol; water at 20 - 30℃; for 1h;96.1%
C29H39NO2

C29H39NO2

abiraterone
154229-19-3

abiraterone

Conditions
ConditionsYield
With hydrogenchloride In methanol; water at 20 - 30℃; for 4h; pH=1 - 2;94%
C20H27F3O4S

C20H27F3O4S

3-Diethylboranylpyridine
89878-14-8

3-Diethylboranylpyridine

abiraterone
154229-19-3

abiraterone

Conditions
ConditionsYield
With bis-triphenylphosphine-palladium(II) chloride; sodium carbonate In tetrahydrofuran; water at 20 - 75℃; for 0.5h;88.8%
17-iodo-5,16-androstadien-3-ol
32138-69-5

17-iodo-5,16-androstadien-3-ol

3-Diethylboranylpyridine
89878-14-8

3-Diethylboranylpyridine

abiraterone
154229-19-3

abiraterone

Conditions
ConditionsYield
With bis-triphenylphosphine-palladium(II) chloride; potassium carbonate; XPhos In 1,4-dioxane for 16h; Reflux;75%
With bis-triphenylphosphine-palladium(II) chloride; sodium carbonate In ethanol; water at 70 - 75℃; for 22h; Solvent; Reagent/catalyst; Temperature;74.1%
With bis-triphenylphosphine-palladium(II) chloride In tetrahydrofuran for 24h; Suzuki Coupling; Reflux; Autoclave; Large scale;72.1%
pyridin-3-ylzinc(II) bromide
220565-63-9

pyridin-3-ylzinc(II) bromide

17-iodo-5,16-androstadien-3-ol
32138-69-5

17-iodo-5,16-androstadien-3-ol

abiraterone
154229-19-3

abiraterone

Conditions
ConditionsYield
With tetrakis(triphenylphosphine) palladium(0) In N,N-dimethyl-formamide at 20℃; for 5h;74.5%
17-iodo-5,16-androstadien-3-ol
32138-69-5

17-iodo-5,16-androstadien-3-ol

pyridin-3-ylmagnesium bromide
21970-14-9

pyridin-3-ylmagnesium bromide

abiraterone
154229-19-3

abiraterone

Conditions
ConditionsYield
With tetrakis(triphenylphosphine) palladium(0) In N,N-dimethyl-formamide at 35℃; for 5h; Temperature;72.31%
3-Diethylboranylpyridine
89878-14-8

3-Diethylboranylpyridine

17-bromo-3β-hydroxy-5α-androstan-5,16-diene
106874-28-6

17-bromo-3β-hydroxy-5α-androstan-5,16-diene

abiraterone
154229-19-3

abiraterone

Conditions
ConditionsYield
With tetrakis(triphenylphosphine) palladium(0); sodium carbonate In water; tert-butyl alcohol for 3h; Catalytic behavior; Solvent; Reagent/catalyst; Temperature; Suzuki Coupling; Inert atmosphere; Reflux; Large scale;72%
17-iodo-5,16-androstadien-3-ol
32138-69-5

17-iodo-5,16-androstadien-3-ol

3-pyridylboronic acid
1692-25-7

3-pyridylboronic acid

abiraterone
154229-19-3

abiraterone

Conditions
ConditionsYield
With bis-triphenylphosphine-palladium(II) chloride; sodium carbonate In water; N,N-dimethyl-formamide at 75 - 80℃; for 36h;71.8%
With palladium on activated charcoal; sodium carbonate In dimethyl sulfoxide at 120℃; for 12h;
3-Diethylboranylpyridine
89878-14-8

3-Diethylboranylpyridine

17-iodoandrosta-5,16-dien-3β-ol 3-acetate

17-iodoandrosta-5,16-dien-3β-ol 3-acetate

abiraterone
154229-19-3

abiraterone

Conditions
ConditionsYield
Stage #1: 3-Diethylboranylpyridine; 17-iodoandrosta-5,16-dien-3β-ol 3-acetate With bis-triphenylphosphine-palladium(II) chloride; sodium carbonate In tetrahydrofuran; water for 5h; Reflux; Large scale;
Stage #2: With sodium hydroxide In methanol at 25 - 35℃; for 7h; Reagent/catalyst; Large scale;
67.8%
Stage #1: 3-Diethylboranylpyridine; 17-iodoandrosta-5,16-dien-3β-ol 3-acetate With bis-triphenylphosphine-palladium(II) chloride; tetrabutyl ammonium fluoride In tetrahydrofuran at 20℃; for 0.333333h;
Stage #2: With sodium carbonate In water at 65 - 70℃; for 1.25h;
Stage #1: 3-Diethylboranylpyridine; 17-iodoandrosta-5,16-dien-3β-ol 3-acetate With bis-triphenylphosphine-palladium(II) chloride; tetrabutyl ammonium fluoride In tetrahydrofuran at 20℃; for 0.333333h;
Stage #2: In tetrahydrofuran at 65 - 70℃; for 1.25h;
34 g
3-(dimethylboryl)pyridine
1003865-86-8

3-(dimethylboryl)pyridine

17-iodo-5,16-androstadien-3-ol
32138-69-5

17-iodo-5,16-androstadien-3-ol

abiraterone
154229-19-3

abiraterone

Conditions
ConditionsYield
With bis-triphenylphosphine-palladium(II) chloride; potassium carbonate In methanol; water at 65 - 70℃; for 28h;65%
C5H4INZn
718628-27-4

C5H4INZn

17-iodo-5,16-androstadien-3-ol
32138-69-5

17-iodo-5,16-androstadien-3-ol

abiraterone
154229-19-3

abiraterone

Conditions
ConditionsYield
With tetrakis(triphenylphosphine) palladium(0) In N,N-dimethyl-formamide at 20℃; for 4h;52.5%
C20H27F3O4S

C20H27F3O4S

pyridin-2-ylboronic acid
197958-29-5

pyridin-2-ylboronic acid

abiraterone
154229-19-3

abiraterone

Conditions
ConditionsYield
With bis-triphenylphosphine-palladium(II) chloride; sodium carbonate In tetrahydrofuran; ethanol; water; toluene at 20 - 75℃; for 2.5h; Time; Suzuki Coupling;51.6%
C26H38O3

C26H38O3

abiraterone
154229-19-3

abiraterone

Conditions
ConditionsYield
With hydroxylamine hydrochloride In acetonitrile Reflux;50%
3-Bromopyridine
626-55-1

3-Bromopyridine

dehydroepiandrosterone-17-p-toluenesulfonyl hydrazone
34988-34-6

dehydroepiandrosterone-17-p-toluenesulfonyl hydrazone

abiraterone
154229-19-3

abiraterone

Conditions
ConditionsYield
Stage #1: dehydroepiandrosterone-17-p-toluenesulfonyl hydrazone With tris-(dibenzylideneacetone)dipalladium(0); lithium tert-butoxide; XPhos In 1,4-dioxane at 20℃; for 0.0833333h;
Stage #2: 3-Bromopyridine With tris-(dibenzylideneacetone)dipalladium(0) In 1,4-dioxane at 120℃; for 9h; Concentration; Temperature; Inert atmosphere;
43.1%
With tris-(dibenzylideneacetone)dipalladium(0); lithium tert-butoxide; XPhos In 1,4-dioxane for 4h; Inert atmosphere; Reflux;
With tris-(dibenzylideneacetone)dipalladium(0); lithium tert-butoxide; XPhos In 1,4-dioxane for 4h; Inert atmosphere; Reflux;
With tris-(dibenzylideneacetone)dipalladium(0); lithium tert-butoxide; XPhos In 1,4-dioxane for 4h; Reflux;
17-iodo-5,16-androstadien-3-ol
32138-69-5

17-iodo-5,16-androstadien-3-ol

pyridin-3-ylzinc chloride
81745-82-6

pyridin-3-ylzinc chloride

abiraterone
154229-19-3

abiraterone

Conditions
ConditionsYield
With tetrakis(triphenylphosphine) palladium(0) In N,N-dimethyl-formamide at 20℃; for 7h;35.7%
dehydroepiandrosterone
53-43-0

dehydroepiandrosterone

3α-hydroxy-androsten-(5)-one-(17)

3α-hydroxy-androsten-(5)-one-(17)

abiraterone
154229-19-3

abiraterone

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: 94 percent / NH2NH2*H2O, aq, NH2NH2*H2SO4 / ethanol / 120 h / Ambient temperature
2: 83 percent / I2, 1,1,3,3-tetramethylguanidine / tetrahydrofuran; diethyl ether / 1 h
3: 2 M aq. Na2CO3 / bis(triphenylphosphine)palladium(II) chloride / tetrahydrofuran / 96 h / 80 °C
View Scheme
dehydroepiandrosterone-17-hydrazone
63015-10-1

dehydroepiandrosterone-17-hydrazone

abiraterone
154229-19-3

abiraterone

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 83 percent / I2, 1,1,3,3-tetramethylguanidine / tetrahydrofuran; diethyl ether / 1 h
2: 2 M aq. Na2CO3 / bis(triphenylphosphine)palladium(II) chloride / tetrahydrofuran / 96 h / 80 °C
View Scheme
Multi-step reaction with 5 steps
1: iodine; N,N,N',N'-tetramethylguanidine / tetrahydrofuran / 1 h / Cooling with ice
2: 1H-imidazole / dichloromethane / 1 h / 20 °C
3: n-butyllithium / tetrahydrofuran / 0.17 h / -78 - -65 °C
4: potassium carbonate; dichloro(1,1'-bis(diphenylphosphanyl)ferrocene)palladium(II)*CH2Cl2 / water; tetrahydrofuran / 15 h / Inert atmosphere; Reflux
5: tetrabutyl ammonium fluoride / tetrahydrofuran
View Scheme
Multi-step reaction with 5 steps
1.1: iodine; N,N,N',N'-tetramethylguanidine / tetrahydrofuran
2.1: 1H-imidazole / dichloromethane / 1.17 h / 20 °C
3.1: triethyl borate / tetrahydrofuran / 0.17 h / -78 °C
3.2: 0.17 h / -65 °C
4.1: sodium carbonate; tetrakis(triphenylphosphine) palladium(0) / water; tetrahydrofuran; toluene / Inert atmosphere; Reflux
5.1: tetrabutyl ammonium fluoride / tetrahydrofuran
View Scheme
prasterone acetate
853-23-6

prasterone acetate

abiraterone
154229-19-3

abiraterone

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: 58 percent / 2,6-di-tert-butyl-4-methylpyridine / CH2Cl2 / 12 h
2: 84 percent / bis(triphenylphosphine)palladium(II) chloride, aq. Na2CO3 / tetrahydrofuran / 1 h / 80 °C
3: 79 percent / aq. NaOH / methanol / 0.08 h / 80 °C
View Scheme
Multi-step reaction with 3 steps
1.1: potassium hexamethylsilazane / tetrahydrofuran / 1 h / -78 °C
1.2: 2 h / -78 °C
2.1: bis-triphenylphosphine-palladium(II) chloride; sodium carbonate / tetrahydrofuran; water / 18 h / Inert atmosphere; Reflux
3.1: potassium hydroxide; methanol / 1.5 h / 20 °C
View Scheme
Multi-step reaction with 3 steps
1: 2,6-dimethylpyridine / dichloromethane / -78 - -20 °C
2: sodium hydrogencarbonate; bis-triphenylphosphine-palladium(II) chloride / tetrahydrofuran; water / 1 h / 60 °C
3: potassium carbonate / methanol / 20 °C
View Scheme
3β-acetoxyandrosta-5,16-dien-17-yl trifluoromethanesulphonate
115375-60-5

3β-acetoxyandrosta-5,16-dien-17-yl trifluoromethanesulphonate

abiraterone
154229-19-3

abiraterone

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 84 percent / bis(triphenylphosphine)palladium(II) chloride, aq. Na2CO3 / tetrahydrofuran / 1 h / 80 °C
2: 79 percent / aq. NaOH / methanol / 0.08 h / 80 °C
View Scheme
Multi-step reaction with 2 steps
1: bis-triphenylphosphine-palladium(II) chloride; sodium carbonate / tetrahydrofuran; water / 18 h / Inert atmosphere; Reflux
2: potassium hydroxide; methanol / 1.5 h / 20 °C
View Scheme
Multi-step reaction with 2 steps
1: sodium hydrogencarbonate; bis-triphenylphosphine-palladium(II) chloride / tetrahydrofuran; water / 1 h / 60 °C
2: potassium carbonate / methanol / 20 °C
View Scheme
Et2

Et2

17-iodo-5,16-androstadien-3-ol
32138-69-5

17-iodo-5,16-androstadien-3-ol

3-Diethylboranylpyridine
89878-14-8

3-Diethylboranylpyridine

abiraterone
154229-19-3

abiraterone

Conditions
ConditionsYield
With sodium carbonate
diethyl ether
60-29-7

diethyl ether

17-iodo-5,16-androstadien-3-ol
32138-69-5

17-iodo-5,16-androstadien-3-ol

3-Diethylboranylpyridine
89878-14-8

3-Diethylboranylpyridine

abiraterone
154229-19-3

abiraterone

Conditions
ConditionsYield
With sodium carbonate In tetrahydrofuran; bis(triphenylphosphine)palladium(II) dichloride
dehydroepiandrosterone
53-43-0

dehydroepiandrosterone

abiraterone
154229-19-3

abiraterone

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: toluene-4-sulfonic acid / tetrahydrofuran / Inert atmosphere; Reflux
2: 1H-imidazole / dichloromethane / 2 h / 20 °C / Inert atmosphere
3: water; tris-(dibenzylideneacetone)dipalladium(0); XPhos; lithium tert-butoxide / 1,4-dioxane / 5 h / Inert atmosphere; Reflux
4: tetrabutyl ammonium fluoride / tetrahydrofuran
View Scheme
Multi-step reaction with 4 steps
1: toluene-4-sulfonic acid / tetrahydrofuran / Inert atmosphere; Reflux
2: 1H-imidazole / dichloromethane / 3 h / 20 °C / Inert atmosphere
3: water; tris-(dibenzylideneacetone)dipalladium(0); XPhos; lithium tert-butoxide / 1,4-dioxane / 6 h / 90 °C / Inert atmosphere
4: tetrabutyl ammonium fluoride / tetrahydrofuran
View Scheme
Multi-step reaction with 6 steps
1: hydrazinium sulfate; hydrazine hydrate / ethanol; water / 72 h / 20 °C
2: iodine; N,N,N',N'-tetramethylguanidine / tetrahydrofuran / 1 h / Cooling with ice
3: 1H-imidazole / dichloromethane / 1 h / 20 °C
4: n-butyllithium / tetrahydrofuran / 0.17 h / -78 - -65 °C
5: potassium carbonate; dichloro(1,1'-bis(diphenylphosphanyl)ferrocene)palladium(II)*CH2Cl2 / water; tetrahydrofuran / 15 h / Inert atmosphere; Reflux
6: tetrabutyl ammonium fluoride / tetrahydrofuran
View Scheme
3-((tert-butyldimethylsilyl)oxy)-17-iodo-5,16-androstadiene
1426400-02-3

3-((tert-butyldimethylsilyl)oxy)-17-iodo-5,16-androstadiene

abiraterone
154229-19-3

abiraterone

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: n-butyllithium / tetrahydrofuran / 0.17 h / -78 - -65 °C
2: potassium carbonate; dichloro(1,1'-bis(diphenylphosphanyl)ferrocene)palladium(II)*CH2Cl2 / water; tetrahydrofuran / 15 h / Inert atmosphere; Reflux
3: tetrabutyl ammonium fluoride / tetrahydrofuran
View Scheme
Multi-step reaction with 3 steps
1.1: triethyl borate / tetrahydrofuran / 0.17 h / -78 °C
1.2: 0.17 h / -65 °C
2.1: sodium carbonate; tetrakis(triphenylphosphine) palladium(0) / water; tetrahydrofuran; toluene / Inert atmosphere; Reflux
3.1: tetrabutyl ammonium fluoride / tetrahydrofuran
View Scheme
3-((tert-butyldimethylsilyl)oxy)-5,16-androstadien-17-boronic acid
1426400-03-4

3-((tert-butyldimethylsilyl)oxy)-5,16-androstadien-17-boronic acid

abiraterone
154229-19-3

abiraterone

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: potassium carbonate; dichloro(1,1'-bis(diphenylphosphanyl)ferrocene)palladium(II)*CH2Cl2 / water; tetrahydrofuran / 15 h / Inert atmosphere; Reflux
2: tetrabutyl ammonium fluoride / tetrahydrofuran
View Scheme
dehydroepiandrosterone-17-p-toluenesulfonyl hydrazone
34988-34-6

dehydroepiandrosterone-17-p-toluenesulfonyl hydrazone

abiraterone
154229-19-3

abiraterone

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: 1H-imidazole / dichloromethane / 2 h / 20 °C / Inert atmosphere
2: water; tris-(dibenzylideneacetone)dipalladium(0); XPhos; lithium tert-butoxide / 1,4-dioxane / 5 h / Inert atmosphere; Reflux
3: tetrabutyl ammonium fluoride / tetrahydrofuran
View Scheme
Multi-step reaction with 3 steps
1: 1H-imidazole / dichloromethane / 2 h / 20 °C / Inert atmosphere
2: tris-(dibenzylideneacetone)dipalladium(0); XPhos; lithium tert-butoxide / 1,4-dioxane / 15 h / 110 °C / Inert atmosphere
3: tetrabutyl ammonium fluoride / tetrahydrofuran
View Scheme
Multi-step reaction with 3 steps
1: 1H-imidazole / dichloromethane / 2.17 h / 20 °C / Inert atmosphere
2: caesium carbonate; dichloro bis(acetonitrile) palladium(II); 1,3-bis-(diphenylphosphino)propane / 1,4-dioxane / 110 °C
3: tetrabutyl ammonium fluoride / tetrahydrofuran
View Scheme
5-dehydroepiandrosterone 2,4,6-trimethylbenzenesulfonyl hydrazone

5-dehydroepiandrosterone 2,4,6-trimethylbenzenesulfonyl hydrazone

abiraterone
154229-19-3

abiraterone

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: 1H-imidazole / dichloromethane / 3 h / 20 °C / Inert atmosphere
2: water; tris-(dibenzylideneacetone)dipalladium(0); XPhos; lithium tert-butoxide / 1,4-dioxane / 6 h / 90 °C / Inert atmosphere
3: tetrabutyl ammonium fluoride / tetrahydrofuran
View Scheme
Multi-step reaction with 3 steps
1: 1H-imidazole / dichloromethane / 3 h / 20 °C / Inert atmosphere
2: tris-(dibenzylideneacetone)dipalladium(0); lithium tert-butoxide; XPhos / water; 1,4-dioxane / 6 h / 90 °C / Inert atmosphere
3: tetrabutyl ammonium fluoride / tetrahydrofuran
View Scheme
BOC-glycine
4530-20-5

BOC-glycine

abiraterone
154229-19-3

abiraterone

tert-butoxycarbonylaminoacetic acid 10,13-dimethyl-17-pyridin-3-yl-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl ester

tert-butoxycarbonylaminoacetic acid 10,13-dimethyl-17-pyridin-3-yl-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl ester

Conditions
ConditionsYield
With dmap; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane at 0 - 20℃; Inert atmosphere;98%
abiraterone
154229-19-3

abiraterone

17-(3-pyridine)-4,16-dieneandrost-3-one
154229-21-7

17-(3-pyridine)-4,16-dieneandrost-3-one

Conditions
ConditionsYield
With aluminum isopropoxide In toluene; butanone Inert atmosphere; Reflux;97%
With aluminum isopropoxide In cyclohexanone; toluene for 2h; Dean-Stark; Reflux;90%
With aluminum isopropoxide; butanone In toluene for 16h; Oppenauer Oxidation; Reflux; Dean-Stark;85%
acetic anhydride
108-24-7

acetic anhydride

abiraterone
154229-19-3

abiraterone

abiraterone acetate
154229-18-2

abiraterone acetate

Conditions
ConditionsYield
With dmap In acetone at 20 - 65℃; for 1h;95.3%
With pyridine; dmap; triethylamine at 0 - 20℃; for 5h;95%
With pyridine In acetonitrile Reflux; Large scale;91.6%
succinic acid mono-tert-butyl ester
15026-17-2

succinic acid mono-tert-butyl ester

abiraterone
154229-19-3

abiraterone

C32H43NO4

C32H43NO4

Conditions
ConditionsYield
With dmap; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane at 20℃; for 6h; Inert atmosphere;95%
1,1'-carbonyldiimidazole
530-62-1

1,1'-carbonyldiimidazole

abiraterone
154229-19-3

abiraterone

C28H33N3O2

C28H33N3O2

Conditions
ConditionsYield
Stage #1: abiraterone With triethylamine In dichloromethane for 0.166667h;
Stage #2: 1,1'-carbonyldiimidazole With dmap In dichloromethane Reflux;
92%
chloroacetyl chloride
79-04-9

chloroacetyl chloride

abiraterone
154229-19-3

abiraterone

abiraterone chloroacetic acid ester

abiraterone chloroacetic acid ester

Conditions
ConditionsYield
Stage #1: abiraterone With pyridine; calcium chloride In tetrahydrofuran at 0℃; for 0.0833333h;
Stage #2: chloroacetyl chloride In tetrahydrofuran at 0 - 20℃; for 10.5h; Solvent; Reagent/catalyst; Concentration; Temperature;
91.3%
acetyl chloride
75-36-5

acetyl chloride

abiraterone
154229-19-3

abiraterone

abiraterone acetate
154229-18-2

abiraterone acetate

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine In diethyl ether at 20℃; for 4h;85.1%
With 2-(Dimethylamino)pyridine; triethylamine In diethyl ether; ethanol; hexane; water84%
With triethylamine In ethyl acetate at 5 - 20℃; for 2h;83%
[2-(tert-butoxycarbonyl-isopropylamino)acetylamino]acetic acid

[2-(tert-butoxycarbonyl-isopropylamino)acetylamino]acetic acid

abiraterone
154229-19-3

abiraterone

[2-(tert-butoxycarbonylisopropylamino)acetylamino]acetic acid 10,13-dimethyl-17-pyridin-3-yl-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl ester

[2-(tert-butoxycarbonylisopropylamino)acetylamino]acetic acid 10,13-dimethyl-17-pyridin-3-yl-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl ester

Conditions
ConditionsYield
With dmap; dicyclohexyl-carbodiimide In dichloromethane at 0 - 20℃; Inert atmosphere;84%
abiraterone
154229-19-3

abiraterone

17β-(3-pyridyl)androst-5-en-3β-ol

17β-(3-pyridyl)androst-5-en-3β-ol

Conditions
ConditionsYield
With hydrazine hydrate; acetic acid In ethanol at 80℃; for 16h;83%
n-tetradecyloxy isopropenyl ether

n-tetradecyloxy isopropenyl ether

abiraterone
154229-19-3

abiraterone

C41H65NO2

C41H65NO2

Conditions
ConditionsYield
With dichloro-acetic acid In dichloromethane at 20℃; Schlenk technique;83%
Acetic anhydride-d6
16649-49-3

Acetic anhydride-d6

abiraterone
154229-19-3

abiraterone

(3β)-17-(3-pyridyl)androst-5,16-dienyl d3-acetate

(3β)-17-(3-pyridyl)androst-5,16-dienyl d3-acetate

Conditions
ConditionsYield
With dmap In acetone at 55 - 65℃; for 2h;82.4%
[Ru(2,2’:6’,2’’-terpyridine)(6,6'-dimethyl-2,2'-dipyridyl)Cl]Cl
1449222-32-5

[Ru(2,2’:6’,2’’-terpyridine)(6,6'-dimethyl-2,2'-dipyridyl)Cl]Cl

abiraterone
154229-19-3

abiraterone

[Ru(2,2':6',2''-terpyridine)(6,6'-dimethyl-2,2'-biquinoline)(abiraterone)]Cl2

[Ru(2,2':6',2''-terpyridine)(6,6'-dimethyl-2,2'-biquinoline)(abiraterone)]Cl2

Conditions
ConditionsYield
In ethanol; water at 80℃; for 20h; Inert atmosphere;81.5%
4-Nitrophenyl chloroformate
7693-46-1

4-Nitrophenyl chloroformate

abiraterone
154229-19-3

abiraterone

abiraterone 4-nitrobenzene carbonate

abiraterone 4-nitrobenzene carbonate

Conditions
ConditionsYield
With dmap at 20℃;80.6%
In tetrahydrofuran at 0℃; for 3h; Reflux;69%
1-methylpiperidine-4-carboxylic acid hydrochloride
71985-80-3

1-methylpiperidine-4-carboxylic acid hydrochloride

abiraterone
154229-19-3

abiraterone

[(3S,8R,9S,10R,13S,14S)-10,13-dimethyl-17-(3-pyridyl)-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-yl] 1-methylpiperidine-4-carboxylate

[(3S,8R,9S,10R,13S,14S)-10,13-dimethyl-17-(3-pyridyl)-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-yl] 1-methylpiperidine-4-carboxylate

Conditions
ConditionsYield
With dmap; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane at 20℃;80%
triisopropylsilyl chloride
13154-24-0

triisopropylsilyl chloride

abiraterone
154229-19-3

abiraterone

3-((3S,8R,9S,10R,13S,14S)-10,13-dimethyl-3-((triisopropylsilyl)oxy)-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl)pyridine

3-((3S,8R,9S,10R,13S,14S)-10,13-dimethyl-3-((triisopropylsilyl)oxy)-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl)pyridine

Conditions
ConditionsYield
Stage #1: abiraterone With 1H-imidazole In dichloromethane at 0℃; for 0.166667h;
Stage #2: triisopropylsilyl chloride In dichloromethane at 20℃; for 44h;
80%
abiraterone
154229-19-3

abiraterone

17-(3-pyridyl)-3,6-dioxoandrosta-4,16-diene
154229-33-1

17-(3-pyridyl)-3,6-dioxoandrosta-4,16-diene

Conditions
ConditionsYield
With dipyridine chromium(VI) oxide In dichloromethane at 20℃; for 4h;75%
4-((9Z,12Z)-octadeca-9,12-dien-1-yloxy)-4-oxobutanoic acid

4-((9Z,12Z)-octadeca-9,12-dien-1-yloxy)-4-oxobutanoic acid

abiraterone
154229-19-3

abiraterone

(3S,8R,9S,10R,13S,14S)-10,13-dimethyl-17-(pyridin-3-yl)-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl linoleylsuccinate

(3S,8R,9S,10R,13S,14S)-10,13-dimethyl-17-(pyridin-3-yl)-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl linoleylsuccinate

Conditions
ConditionsYield
With dmap; dicyclohexyl-carbodiimide In dichloromethane for 14h; Inert atmosphere; Cooling with ice;60%

Abiraterone Specification

1. Introduction of Abiraterone
Abiraterone is one kind of white powder. Abiraterone IUPAC name is called (3S,8R,9S,10R,13S,14S)-10,13-Dimethyl-17-pyridin-3-yl-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-ol. Abiraterone belongs to the product categories of API; Intermediates & Fine Chemicals; Pharmaceuticals; Steroids. Lipophilic compound is a Lipophilic compound and can not soluble in water.

2. Properties of Abiraterone
Physical properties about Abiraterone are:
(1)ACD/LogP: 5.661; (2)# of Rule of 5 Violations: 1; (3)ACD/LogD (pH 5.5): 5.45; (4)ACD/LogD (pH 7.4): 5.66; (5)ACD/BCF (pH 5.5): 7195.82; (6)ACD/BCF (pH 7.4): 11721.29; (7)ACD/KOC (pH 5.5): 17428.90; (8)ACD/KOC (pH 7.4): 28390.01; (9)#H bond acceptors: 2; (10)#H bond donors: 1; (11)#Freely Rotating Bonds: 2; (12)Polar Surface Area: 33.12 Å2; (13)Index of Refraction: 1.606; (14)Molar Refractivity: 105.19 cm3; (15)Molar Volume: 305.16 cm3; (16)Surface Tension: 50.07 dyne/cm; (17)Density: 1.145 g/cm3; (18)Flash Point: 256.294 °C; (19)Enthalpy of Vaporization: 80.951 kJ/mol; (20)Boiling Point: 500.17 °C at 760 mmHg; (21)Vapour Pressure: 0 mmHg at 25 °C.

3. Structure Descriptors of Abiraterone
(1) SMILES: O[C@@H]2C/C1=C/C[C@@H]4[C@@H]([C@@]1(C)CC2)CC[C@@]3(C(=C/C[C@H]34)\c5cccnc5)C
(2) InChI: InChI=1S/C24H31NO/c1-23-11-9-18(26)14-17(23)5-6-19-21-8-7-20(16-4-3-13-25-15-16)24(21,2)12-10-22(19)23/h3-5,7,13,15,18-19,21-22,26H,6,8-12,14H2,1-2H3/t18-,19-,21-,22-,23-,24+/m0/s1
(3) InChIKey: GZOSMCIZMLWJML-VJLLXTKPSA-N

4. Uses of Abiraterone
Abiraterone is a drug used in castration-resistant prostate cancer. It is formulated as the prodrug abiraterone acetate. Abiraterone can be used as a prostate cancer drug treatment. Abiraterone is a inhibitor of CYP17. It can be used to treat CRPC.

5. History of Abiraterone
This drug was discovered by Gerry Potter in 1990 at the Cancer Research UK Centre for Cancer Therapeutics within the Institute of Cancer Research in London. Rights for commercialisation of the drug were assigned to BTG plc, a UK company that manages commercialisation activity in pharmaceuticals. BTG then licenced the product to Cougar Biotechnology which began development of the commercial product. In 2009, Cougar was acquired by Johnson & Johnson which developed and sells the commercial product, and is conducting ongoing clinical trials to expand its clinical uses.

Post buying leads

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View